1. Home
  2. NNNN vs GDOT Comparison

NNNN vs GDOT Comparison

Compare NNNN & GDOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NNNN
  • GDOT
  • Stock Information
  • Founded
  • NNNN 2021
  • GDOT 1999
  • Country
  • NNNN Germany
  • GDOT United States
  • Employees
  • NNNN N/A
  • GDOT N/A
  • Industry
  • NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • GDOT Finance: Consumer Services
  • Sector
  • NNNN Health Care
  • GDOT Finance
  • Exchange
  • NNNN Nasdaq
  • GDOT Nasdaq
  • Market Cap
  • NNNN 369.6M
  • GDOT 363.9M
  • IPO Year
  • NNNN 2025
  • GDOT 2010
  • Fundamental
  • Price
  • NNNN $16.10
  • GDOT $9.55
  • Analyst Decision
  • NNNN
  • GDOT Hold
  • Analyst Count
  • NNNN 0
  • GDOT 3
  • Target Price
  • NNNN N/A
  • GDOT $10.33
  • AVG Volume (30 Days)
  • NNNN 78.0K
  • GDOT 814.6K
  • Earning Date
  • NNNN 01-01-0001
  • GDOT 08-07-2025
  • Dividend Yield
  • NNNN N/A
  • GDOT N/A
  • EPS Growth
  • NNNN N/A
  • GDOT N/A
  • EPS
  • NNNN 0.06
  • GDOT N/A
  • Revenue
  • NNNN $8,185,146.00
  • GDOT $1,825,327,000.00
  • Revenue This Year
  • NNNN N/A
  • GDOT $22.44
  • Revenue Next Year
  • NNNN N/A
  • GDOT $12.64
  • P/E Ratio
  • NNNN $286.95
  • GDOT N/A
  • Revenue Growth
  • NNNN 21.95
  • GDOT 18.98
  • 52 Week Low
  • NNNN $5.18
  • GDOT $6.13
  • 52 Week High
  • NNNN $18.50
  • GDOT $13.58
  • Technical
  • Relative Strength Index (RSI)
  • NNNN N/A
  • GDOT 49.89
  • Support Level
  • NNNN N/A
  • GDOT $9.36
  • Resistance Level
  • NNNN N/A
  • GDOT $11.07
  • Average True Range (ATR)
  • NNNN 0.00
  • GDOT 0.43
  • MACD
  • NNNN 0.00
  • GDOT -0.08
  • Stochastic Oscillator
  • NNNN 0.00
  • GDOT 23.71

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

About GDOT Green Dot Corporation $0.001 par value

Green Dot Corp is a financial technology company that provides financial services for consumers in the United States without good banking options. It has three segments Consumer Services, Business to Business Services(B2B), and Money Movement Services. The company generates maximum revenue from B2B segment. Its B2B Services segment consists of revenues and expenses derived from (i) its partnerships with prominent consumer and technology companies that make banking products and services available to their consumers, partners and workforce through integration with its banking platform (the "Banking-as-a-Service", or "BaaS channel"), and (ii) a comprehensive payroll platform that it offers to corporate enterprises (the "Employer channel") to facilitate payments for today's workforce.

Share on Social Networks: